Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease

A. J. H. Moonen, A. Wijers, A. F. G. Leentjens, C. W. Christine, S. A. Factor, J. Juncos, J. M. Lyness, L. Marsh, M. Panisset, R. Pfeiffer, D. Rottenberg, C. Serrano Ramos, L. Shulman, C. Singer, J. Slevin, W. McDonald, P. Auinger, I. H. Richard

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)
Original languageEnglish
Pages (from-to)644-646
JournalParkinsonism & Related Disorders
Volume20
Issue number6
DOIs
Publication statusPublished - Jun 2014

Keywords

  • Parkinson's disease
  • Depression
  • Clinical trials randomized controlled
  • Venlafaxine
  • Paroxetine

Cite this

Moonen, A. J. H., Wijers, A., Leentjens, A. F. G., Christine, C. W., Factor, S. A., Juncos, J., Lyness, J. M., Marsh, L., Panisset, M., Pfeiffer, R., Rottenberg, D., Ramos, C. S., Shulman, L., Singer, C., Slevin, J., McDonald, W., Auinger, P., & Richard, I. H. (2014). Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease. Parkinsonism & Related Disorders, 20(6), 644-646. https://doi.org/10.1016/j.parkreldis.2014.02.025